Key result
Lycopene administration significantly reduced the expression of inflammatory, fibrotic, and apoptotic markers in mice post-myocardial infarction by inhibiting the NF-κB signaling pathway.
Why the study?
Does lycopene reduce inflammation, apoptosis, and ventricular remodeling in a mouse model of post-myocardial infarction?
Does lycopene reduce inflammation, apoptosis, and ventricular remodeling in a mouse model of post-myocardial infarction?
p-value: p=<0.05
Lycopene attenuates post-myocardial infarction ventricular remodeling, inflammation, and apoptosis in mice, likely by inhibiting the NF-κB signaling pathway.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications for lycopene post-MI; leaves open translation of NF-κB effects to human remodeling trials.
He et al. (2014) studied Myocardial Infarction. Lycopene vs. Normal saline was evaluated on Expression of fibrosis markers (TGF-β1, collagen I and III), inflammatory markers (TNF-α, IL-1β), and apoptotic markers (caspase-3, -8, -9) (p=<0.05). Lycopene administration significantly reduced the expression of inflammatory, fibrotic, and apoptotic markers in mice post-myocardial infarction by inhibiting the NF-κB signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: